Clomipramine, and to a lesser extent the other tricyclics, have a profound effect on central 5-HT transmission resulting in an increase in post-synaptic receptor stimulation." Other drugs with this effect, the 5-HT precursor 5-hydroxytrypthophan (5-HTP) and the monoamine oxidase inhibitor phenelzine
The prevalence of the narcoleptic syndrome is unknown, but it has been estimated that up to 100 000 people may be affected in the United States.' About 80 % of narcoleptics also have cataplexy.
Sympathomimetic drugs, which relieve narcolepsy, have little or no effect on cataplexy. Many patients therefore require treatment with two drugs, and occasionally more. 2 Akimoto et a13 found that imipramine had an excellent effect selectively on cataplexy without affecting sleep attacks. Brodie et a14 later reported that desmethylimipramine had a more active and more rapid antidepressant effect than imipramine. Subsequently, Hishikawa et a15 gave desmethylimipramine to 23 patients with narcolepsy and cataplexy and found that the drug was at least as effective as imipramine in preventing cataplexy and had fewer side effects. Clomipramine, introduced by Passouant et al,6 is more active than either of these drugs and causes a 50% or greater reduction in the frequency of cataplexy in the majority of subjects; tolerance and side effects, however, can limit effective treatment. [7] [8] [9] [10] Clomipramine, and to a lesser extent the other tricyclics, have a profound effect on central 5-HT transmission resulting in an increase in post-synaptic receptor stimulation." Other drugs with this effect, the 5-HT precursor 5-hydroxytrypthophan (5-HTP) and the monoamine oxidase inhibitor phenelzine 5-HTP is also doubtful.10 Wyatt et a1'3 gave the monoamine oxidase inhibitor phenelzine to seven patients with narcolepsy and cataplexy, and noted some improvement in both symptoms. All these drugs, in the doses used, may alter 5-HT receptor activity in the brain, but another tricyclic drug, protriptyline, is a very potent noradrenaline reuptake blocker with weak effects on the 5-HT system, also seems to be effective in cataplexy. 20 We conclude that, despite the somewhat contra- 
